Cargando…
Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines
Japanese encephalitis virus (JEV) is the causal agent behind Japanese encephalitis (JE), a potentially severe brain infection that spreads through mosquito bites. JE is predominant over the Asia-Pacific Region and has the potential to spread globally with a higher rate of morbidity and mortality. Ef...
Autores principales: | Srivastava, Kumar Saurabh, Jeswani, Vandana, Pal, Nabanita, Bohra, Babita, Vishwakarma, Vaishali, Bapat, Atharva Ashish, Patnaik, Yamini Prashanti, Khanna, Navin, Shukla, Rahul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146181/ https://www.ncbi.nlm.nih.gov/pubmed/37112654 http://dx.doi.org/10.3390/vaccines11040742 |
Ejemplares similares
-
Recent Advances in Antivirals for Japanese Encephalitis Virus
por: Zhu, Yongzhe, et al.
Publicado: (2023) -
Antiviral drug research for Japanese encephalitis: an updated review
por: Joe, Shaun, et al.
Publicado: (2022) -
Antiviral Activity of Baicalein and Quercetin against the Japanese Encephalitis Virus
por: Johari, Jefree, et al.
Publicado: (2012) -
Antiviral potential of 4-hydroxypanduratin A, secondary metabolite of Fingerroot, Boesenbergia pandurata (Schult.), towards Japanese Encephalitis virus NS2B/NS3 protease
por: Seniya, Chandrabhan, et al.
Publicado: (2013) -
Chronic T Cell Encephalitis Responsive to Immunotherapy
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2022)